Shenzhen Glory Medical Co.,Ltd. (002551.SZ)
CNY 3.58
(-0.83%)
CNY 3.58
(-0.83%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 155 Million CNY | -10.94% |
| 2022 | 221.87 Million CNY | -38.87% |
| 2021 | 362.93 Million CNY | -47.76% |
| 2020 | 694.7 Million CNY | 110.63% |
| 2019 | 329.82 Million CNY | -17.95% |
| 2018 | 401.97 Million CNY | -14.97% |
| 2017 | 472.74 Million CNY | -0.47% |
| 2016 | 474.99 Million CNY | 8.76% |
| 2015 | 436.73 Million CNY | 32.24% |
| 2014 | 330.27 Million CNY | 48.42% |
| 2013 | 222.53 Million CNY | 38.6% |
| 2012 | 160.55 Million CNY | 52.49% |
| 2011 | 105.28 Million CNY | -1.88% |
| 2010 | 107.3 Million CNY | 24.42% |
| 2009 | 86.24 Million CNY | 47.34% |
| 2008 | 58.53 Million CNY | 28.23% |
| 2007 | 45.64 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 62.34 Million CNY | 109.36% |
| 2024 Q2 | 29.78 Million CNY | -33.34% |
| 2024 Q1 | 44.67 Million CNY | 85.74% |
| 2023 Q2 | 57.44 Million CNY | -4.01% |
| 2023 Q3 | 56.26 Million CNY | -2.05% |
| 2023 Q4 | 24.05 Million CNY | -57.25% |
| 2023 FY | 197.6 Million CNY | -10.94% |
| 2023 Q1 | 59.84 Million CNY | 35.89% |
| 2022 Q3 | 70.65 Million CNY | 84.28% |
| 2022 Q2 | 38.34 Million CNY | -44.3% |
| 2022 Q1 | 68.83 Million CNY | 774.5% |
| 2022 Q4 | 44.03 Million CNY | -37.67% |
| 2022 FY | 221.87 Million CNY | -38.87% |
| 2021 Q3 | 75.52 Million CNY | -16.99% |
| 2021 Q4 | 7.87 Million CNY | -89.58% |
| 2021 Q2 | 90.98 Million CNY | -51.74% |
| 2021 Q1 | 188.55 Million CNY | -6.98% |
| 2021 FY | 362.93 Million CNY | -47.76% |
| 2020 Q4 | 202.69 Million CNY | 17.95% |
| 2020 FY | 694.7 Million CNY | 110.63% |
| 2020 Q1 | 91.71 Million CNY | 71.75% |
| 2020 Q2 | 228.44 Million CNY | 149.08% |
| 2020 Q3 | 171.84 Million CNY | -24.78% |
| 2019 Q3 | 75.31 Million CNY | -34.49% |
| 2019 Q4 | 53.4 Million CNY | -29.1% |
| 2019 FY | 329.82 Million CNY | -17.95% |
| 2019 Q1 | 86.13 Million CNY | 44.93% |
| 2019 Q2 | 114.96 Million CNY | 33.47% |
| 2018 Q3 | 66.31 Million CNY | -52.46% |
| 2018 Q1 | 136.72 Million CNY | 10.4% |
| 2018 FY | 401.97 Million CNY | -14.97% |
| 2018 Q4 | 59.43 Million CNY | -10.38% |
| 2018 Q2 | 139.5 Million CNY | 2.03% |
| 2017 Q4 | 123.84 Million CNY | 28.11% |
| 2017 Q2 | 109.54 Million CNY | -23.22% |
| 2017 Q3 | 96.67 Million CNY | -11.76% |
| 2017 FY | 472.74 Million CNY | -0.47% |
| 2017 Q1 | 142.67 Million CNY | 21.63% |
| 2016 Q1 | 124.93 Million CNY | 4.71% |
| 2016 Q3 | 106.65 Million CNY | -15.41% |
| 2016 Q4 | 117.3 Million CNY | 9.98% |
| 2016 FY | 474.99 Million CNY | 8.76% |
| 2016 Q2 | 126.09 Million CNY | 0.93% |
| 2015 Q4 | 119.31 Million CNY | -2.57% |
| 2015 Q2 | 100.23 Million CNY | 5.83% |
| 2015 Q1 | 94.71 Million CNY | -6.26% |
| 2015 FY | 436.73 Million CNY | 32.24% |
| 2015 Q3 | 122.46 Million CNY | 22.17% |
| 2014 FY | 330.27 Million CNY | 48.42% |
| 2014 Q2 | 77.98 Million CNY | 24.16% |
| 2014 Q4 | 101.03 Million CNY | 14.25% |
| 2014 Q3 | 88.43 Million CNY | 13.41% |
| 2014 Q1 | 62.81 Million CNY | -17.8% |
| 2013 Q2 | 51.26 Million CNY | 25.05% |
| 2013 FY | 222.53 Million CNY | 38.6% |
| 2013 Q3 | 53.86 Million CNY | 5.07% |
| 2013 Q4 | 76.41 Million CNY | 41.87% |
| 2013 Q1 | 40.99 Million CNY | -4.04% |
| 2012 Q4 | 42.72 Million CNY | 2.54% |
| 2012 Q1 | 37.54 Million CNY | 230.21% |
| 2012 Q2 | 38.62 Million CNY | 2.89% |
| 2012 Q3 | 41.66 Million CNY | 7.85% |
| 2012 FY | 160.55 Million CNY | 52.49% |
| 2011 Q4 | 11.36 Million CNY | -54.44% |
| 2011 Q2 | 39.04 Million CNY | 30.47% |
| 2011 Q1 | 29.92 Million CNY | -51.04% |
| 2011 FY | 105.28 Million CNY | -1.88% |
| 2011 Q3 | 24.95 Million CNY | -36.08% |
| 2010 Q3 | 30.34 Million CNY | -11.18% |
| 2010 Q1 | 19.23 Million CNY | 0.0% |
| 2010 Q2 | 34.16 Million CNY | 77.62% |
| 2010 Q4 | 61.12 Million CNY | 101.42% |
| 2010 FY | 107.3 Million CNY | 24.42% |
| 2009 FY | 86.24 Million CNY | 47.34% |
| 2008 FY | 58.53 Million CNY | 28.23% |
| 2007 FY | 45.64 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| China National Accord Medicines Corporation Ltd. | 9 Billion CNY | 98.279% |
| Realcan Pharmaceutical Group Co., Ltd. | 822.06 Million CNY | 81.144% |